Rodrigo Machado-Vieira

2 presentations

• A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF THE FATTY ACID AMIDE HYDROLASE INHIBITOR PALMITOYLETHANOLAMIDE IN BIPOLAR DEPRESSION

  2026 ASCP Annual Meeting

• W59. A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF THE FATTY ACID AMIDE HYDROLASE INHIBITOR PALMITOYLETHANOLAMIDE IN BIPOLAR DEPRESSION

  2026 ASCP Annual Meeting